pyridinolcarbamate has been researched along with Myocardial Ischemia in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garmash, VIa | 1 |
| Uzbekova, DG | 1 |
| Artem'eva, GB | 1 |
| Rakita, DR | 1 |
1 other study available for pyridinolcarbamate and Myocardial Ischemia
| Article | Year |
|---|---|
[The use of the antioxidant effect of parmidine in the combined therapy of patients with ischemic heart disease].
Topics: Antioxidants; Drug Evaluation; Drug Therapy, Combination; Humans; Male; Myocardial Ischemia; Pyridin | 1996 |